ALT vs KEY · rev $20.0K vs P/E 13, rev $7.51B
Altimmune Inc (ALT) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
ALT currently screens at market cap $527.0M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the ALT and KEY stock pages for the full models.
Not investment advice.